Valuation Laboratorio Reig Jofre, S.A.

Stocks

Market Closed - BME 12:35:00 2026-10-26 EDT			5-day change	1st Jan Change
2.550 ^EUR	-1.16%		-2.30%	-0.78%

07-30	Laboratorio Reig Jofre, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-16	Spanish stocks - Factors to watch on June 16	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	250.8	170.1	177.3	199.3	209.2	209.3	-	-
Change	-	-32.16%	4.21%	12.43%	4.93%	0.06%	-	-
Enterprise Value (EV) ¹	313.1	224.9	210.5	247.4	290.2	294	288	281
Change	-	-28.16%	-6.41%	17.51%	17.3%	1.31%	-2.04%	-2.43%
P/E	46.6x	21.9x	18.8x	19.2x	42.8x	12.8x	21.3x	15.9x
PBR	1.33x	-	0.87x	-	-	-	-	-
PEG	-	0.5x	0.9x	2.3x	-0.8x	0x	-0.5x	0.5x
Capitalization / Revenue	1.06x	0.63x	0.56x	0.59x	0.63x	0.57x	0.53x	0.5x
EV / Revenue	1.33x	0.83x	0.67x	0.73x	0.88x	0.81x	0.73x	0.67x
EV / EBITDA	11.5x	7.6x	6.26x	6.88x	10x	8.26x	7.24x	6.44x
EV / EBIT	35.3x	26.4x	20x	19.6x	68.5x	12x	18.9x	14.5x
EV / FCF	-59.5x	43.2x	31.6x	22.3x	-21.1x	-62.6x	48x	39.6x
FCF Yield	-1.68%	2.31%	3.16%	4.48%	-4.75%	-1.6%	2.08%	2.53%
Dividend per Share ²	0.04	-	-	-	-	-	-	-
Rate of return	1.23%	-	-	-	-	-	-	-
EPS ²	0.07	0.1	0.12	0.13	0.06	0.2	0.12	0.16
Distribution rate	57.1%	-	-	-	-	-	-	-
Net sales ¹	236.2	271.2	316.1	338.9	331.1	364.9	391.9	419.9
EBITDA ¹	27.35	29.6	33.66	35.97	29.02	35.6	39.8	43.6
EBIT ¹	8.863	8.532	10.51	12.61	4.235	24.4	15.2	19.4
Net income ¹	5.092	8.107	9.407	10.38	5.021	16.7	9.5	12.9
Net Debt ¹	62.32	54.79	33.22	48.03	81	84.7	78.7	71.7
Reference price ²	3.260	2.190	2.250	2.490	2.570	2.550	2.550	2.550
Nbr of stocks (in thousands)	76,935	77,694	78,802	80,060	81,391	82,076	-	-
Announcement Date	2/28/22	2/28/23	2/29/24	2/28/25	2/26/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LABORATORIO REIG JOFRE, S.A.	12.9x	0.81x	8.33x	-	237M
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.33x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	27.84x	6.42x	17.66x	2.12%	400.39B
Weighted average by Cap.	35.23x	8.29x	20.40x	1.8%